CAR T Cell Therapy for Multiple Sclerosis: A UK First

In a groundbreaking trial, a UK patient with Multiple Sclerosis (MS) receives CAR T cell therapy for the first time. This personalized treatment, invented by UCL researchers, aims to slow or halt MS progression by resetting the immune system. Emily Henders, the first recipient, shares her experience and hopes for the future. Learn about the science behind CAR T cell therapy, its potential impact on MS, and the journey towards finding a cure.
This video explores:
What is Multiple Sclerosis and its impact on the nervous system?
How does CAR T cell therapy work and why is it promising for MS patients?
The story of Emily Henders and her determination to fight MS.
The research team's insights and goals for this innovative treatment.